Postdeployment Respiratory Health Care Encounters Following Deployment to Kabul, Afghanistan: A Retrospective Cohort Study. Issue 3 (1st March 2016)

• Record Type: Journal Article
• Authors: Sharkey, Jessica M.; Abraham, Joseph H.; Clark, Leslie L.; Rohrbeck, Patricia; Ludwig, Sharon L.; Hu, Zheng; Baird, Coleen P.
• Is Part Of: Military medicine. Volume 181:Issue 3(2016)
• Page Start: 265
• Page End: 271
• Publication Date: 2016-03-01
• Subjects: Surgery, Military -- Societies, etc; Medicine, Military -- Societies, etc; Medicine, Military -- Periodicals; Surgery, Military -- Periodicals; Medicine, Military; Surgery, Military; Military Medicine -- Periodicals; Periodicals; Electronic journals; 616.98023
• DOI: 10.7205/MILMED-D-14-00690
• Languages: English
• ISSNs: 0026-4075

Abstract

ABSTRACT: Inhalational hazards are numerous in operational environments. A retrospective cohort study was conducted to investigate associations between deployment to Kabul, Afghanistan and subsequent respiratory health among U.S. military personnel. The study population consisted of personnel who deployed to Kabul, select Operation Enduring Freedom locations, personnel stationed in the Republic of Korea, and U.S.-stationed personnel. Incidence rate ratios (IRRs) were estimated for respiratory symptoms, signs, and ill-defined conditions, asthma, and chronic obstructive pulmonary disease. A significantly elevated rate of symptoms, signs, and ill-defined conditions was observed among Kabul-deployed personnel compared to personnel deployed or stationed in Bagram (IRR 1.12; 95% confidence interval [CI], 1.05–1.19), Republic of Korea (IRR 1.20; 95% CI, 1.10–1.31), and the United States (IRR 1.52; 95% CI, 1.43–1.62). A statistically elevated rate of asthma was observed among personnel deployed to Kabul, relative to U.S.-stationed personnel (IRR 1.61; 95% CI, 1.22–2.12). Statistically significant rates were not observed for chronic obstructive pulmonary disease among Kabul-deployed personnel compared to other study groups. These findings suggest that deployment to Kabul is associated with an elevated risk of postdeployment respiratory symptoms and new-onset asthma.